1. Home
  2. RAPT vs CXE Comparison

RAPT vs CXE Comparison

Compare RAPT & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • CXE
  • Stock Information
  • Founded
  • RAPT 2015
  • CXE 1989
  • Country
  • RAPT United States
  • CXE United States
  • Employees
  • RAPT N/A
  • CXE N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • CXE Investment Managers
  • Sector
  • RAPT Health Care
  • CXE Finance
  • Exchange
  • RAPT Nasdaq
  • CXE Nasdaq
  • Market Cap
  • RAPT 117.5M
  • CXE 110.0M
  • IPO Year
  • RAPT 2019
  • CXE N/A
  • Fundamental
  • Price
  • RAPT $0.79
  • CXE $3.49
  • Analyst Decision
  • RAPT Hold
  • CXE
  • Analyst Count
  • RAPT 7
  • CXE 0
  • Target Price
  • RAPT $5.00
  • CXE N/A
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • CXE 62.9K
  • Earning Date
  • RAPT 05-08-2025
  • CXE 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • CXE 4.36%
  • EPS Growth
  • RAPT N/A
  • CXE N/A
  • EPS
  • RAPT N/A
  • CXE 0.07
  • Revenue
  • RAPT N/A
  • CXE N/A
  • Revenue This Year
  • RAPT N/A
  • CXE N/A
  • Revenue Next Year
  • RAPT N/A
  • CXE N/A
  • P/E Ratio
  • RAPT N/A
  • CXE $51.00
  • Revenue Growth
  • RAPT N/A
  • CXE N/A
  • 52 Week Low
  • RAPT $0.79
  • CXE $2.95
  • 52 Week High
  • RAPT $8.58
  • CXE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 31.31
  • CXE 32.33
  • Support Level
  • RAPT $0.81
  • CXE $3.44
  • Resistance Level
  • RAPT $0.98
  • CXE $3.51
  • Average True Range (ATR)
  • RAPT 0.10
  • CXE 0.06
  • MACD
  • RAPT -0.03
  • CXE -0.01
  • Stochastic Oscillator
  • RAPT 7.72
  • CXE 31.43

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About CXE MFS High Income Municipal Trust

Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.

Share on Social Networks: